Current Cancer Drug Targets

Papers
(The H4-Index of Current Cancer Drug Targets is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The Expression of Glutaminases and their Association with Clinicopathological Parameters in the Head and Neck Cancers85
Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway43
Spinal KCC2 Mediates the Modulation Effect of HDAC2 on Bone Cancer Pain in Rats40
Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice34
A Pilot Study of Anlotinib as a Combination Treatment in Advanced Nasopharyngeal Carcinoma30
Unveiling Novel Therapeutic Drug Targets and Prognostic Markers of Triple Negative Breast Cancer26
Silencing HEATR1 Rescues Cisplatin Resistance of Non-small Cell Lung Cancer by Inducing Ferroptosis via the p53/SAT1/ALOX15 Axis25
Expression, Prognostic Value, and Immune Infiltration of MTHFD Family in Bladder Cancer24
Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma24
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway23
The Therapeutic Potential of Urolithin A for Cancer Treatment and Prevention22
Immune Checkpoint Inhibitors for Advanced Biliary Tract Cancer22
Bioinformatics and Experimental Study Revealed LINC00982/ miR-183-5p/ABCA8 Axis Suppresses LUAD Progression16
TBOPP, a DOCK1 Inhibitor, Potentiates Cisplatin Efficacy in Breast Cancer by Regulating Twist-mediated EMT15
Etiology-based Molecular Characterization of Hepatocellular Carcinoma Reveals SQLE’s Contribution to Immunosuppressive Microenvironment14
LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression14
Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications14
0.18567299842834